Treatment of patients with ibandronate and correlation with serum carboxyterminal telopeptide of type I collagen levels

被引:0
|
作者
Galanopoulos, A
Arseni, P
Michalis, E
Marinakis, T
Gortzolidis, G
Zomas, A
Tsipra, M
Ragousi, M
Anagnostopoulos, NI
机构
[1] Gen G Gennimatas Hosp, Athens, Greece
[2] Trauma Hosp, Res Ctr, Athens, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6734
引用
收藏
页码:615S / 615S
页数:1
相关论文
共 50 条
  • [41] Serum tartrate-resistant acid phosphatase 5b and carboxyterminal telopeptide of type I collagen as markers of bone metastases in breast cancer
    Korpela, J
    Alatalo, SL
    Halleen, JM
    Väänänen, HK
    Hinkka, S
    Suominen, P
    Salminen, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 135 - 136
  • [42] SERUM CONCENTRATIONS OF CARBOXYTERMINAL CROSS-LINKED TELOPEPTIDE OF TYPE-I COLLAGEN (ICTP), SERUM TARTRATE-RESISTANT ACID-PHOSPHATASE, AND SERUM LEVELS OF INTACT PARATHYROID-HORMONE IN PARATHYROID HYPERFUNCTION
    DELAPIEDRA, C
    MARTIN, MAD
    DIEGO, EMD
    GAVILANES, EL
    PARRA, EG
    CARAMELO, C
    RAPADO, A
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (01): : 11 - 15
  • [43] Palliative treatment of bone metastases in hormone-refractory prostate cancer: Effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels
    Kawashima, Hidenori
    Tanaka, Tomoaki
    Kuratsukuri, Katsuyuki
    Uchida, Junji
    Sugimura, Kazunobu
    Tamada, Satoshi
    Nishisaka, Nobuyasu
    Kumata, Katsuyuki
    Iwai, Yoshihito
    Ikemoto, Shinichi
    Ezaki, Kazuyoshi
    Nakatani, Tatsuya
    UROLOGIA INTERNATIONALIS, 2007, 78 (04) : 345 - 350
  • [44] Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy- and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer
    Tahtela, R
    Tholix, E
    ANTICANCER RESEARCH, 1996, 16 (4B) : 2289 - 2293
  • [45] Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline
    Reiko Okabe
    Masaaki Inaba
    Kiyoshi Nakatsuka
    Takami Miki
    Hiroshi Naka
    Atushi Moriguchi
    Yoshiki Nishizawa
    Journal of Bone and Mineral Metabolism, 2004, 22 : 127 - 131
  • [46] INCREASED SERUM LEVELS OF CARBOXYTERMINAL PROPEPTIDE OF TYPE-1 COLLAGEN (PICP) IN HYPERTHYROIDISM
    LEGOVINI, P
    DEMENIS, E
    DARIN, G
    ROITER, I
    BREDA, F
    ARTUSO, V
    DIVIRGILIO, R
    CONTE, N
    HORMONE AND METABOLIC RESEARCH, 1994, 26 (07) : 334 - 337
  • [47] Correlation of urine type I collagen-cross-linked N telopeptide levels with bone scintigraphic results in prostate cancer patients
    Fukumitsu, N
    Uchiyama, M
    Mori, Y
    Yanada, S
    Hatano, T
    Igarashi, H
    Kishimoto, K
    Nakada, J
    Yoshihiro, A
    Harada, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07): : 814 - 818
  • [48] Measurement of C-terminal telopeptide of type I collagen (CTX) in serum
    Chubb, S. A. Paul
    CLINICAL BIOCHEMISTRY, 2012, 45 (12) : 928 - 935
  • [49] A serum EIA for C-telopeptide of human type I collagen.
    Leeddecke, BA
    Sinykin, C
    Finn, S
    Scheller, D
    Salvati, M
    Srivastava, AK
    Mohan, S
    Baylink, D
    CLINICAL CHEMISTRY, 1997, 43 : 220 - 220
  • [50] Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients
    Okuno, S
    Inaba, M
    Kitatani, K
    Ishimura, E
    Yamakawa, T
    Nishizawa, Y
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (05) : 501 - 509